Skip to main content

shareholder_rights

Law Firm Probes $46.72/Share John Marshall-Eagle Financial Merger Terms

Image
Law Firm Probes $46.72/Share John Marshall-Eagle Financial Merger Terms

Milwaukee – September 12, 2026 -- Ademi LLP has launched an investigation into the proposed acquisition of Eagle Financial Services, Inc. (Nasdaq: EFSI) by John Marshall Bancorp, questioning whether the deal's terms deliver fair value to EFSI's public shareholders.

Deal terms value EFSI shares at $46.72 based on a fixed exchange ratio

Under the agreement, EFSI shareholders will receive 2.0 shares of John Marshall common stock for each EFSI share held. That exchange ratio implies a per-share value of $46.72, calculated using John Marshall's closing stock price of $23.36 on September 4, 2026.

Law Firm Probes Fairness of Four Pending Mergers Including Bio-Techne, Caesars Deals

Image
Law Firm Probes Fairness of Four Pending Mergers Including Bio-Techne, Caesars Deals

New York – September 11, 2026 -- Monteverde & Associates PC has opened investigations into four pending mergers, questioning whether shareholders of Bio-Techne, Caesars Entertainment, Colony Bankcorp and Auddia are receiving fair value under the proposed deal terms.

Bio-Techne shareholders face $73.00-per-share cash buyout from Merck KGaA

Bio-Techne Corporation (NASDAQ: TECH) agreed to a sale to Merck KGaA under which shareholders are expected to receive $73.00 per share in cash. Monteverde & Associates is examining whether the price reflects fair value ahead of the deal's closing.